nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—CYP2B6—Efavirenz—acquired immunodeficiency syndrome	0.0697	0.0975	CbGbCtD
Raloxifene—CYP2B6—Lopinavir—acquired immunodeficiency syndrome	0.0656	0.0916	CbGbCtD
Raloxifene—CYP2B6—Nevirapine—acquired immunodeficiency syndrome	0.0656	0.0916	CbGbCtD
Raloxifene—CYP2B6—Amprenavir—acquired immunodeficiency syndrome	0.0593	0.0829	CbGbCtD
Raloxifene—CYP2B6—Nelfinavir—acquired immunodeficiency syndrome	0.0497	0.0695	CbGbCtD
Raloxifene—CYP2B6—Ritonavir—acquired immunodeficiency syndrome	0.0449	0.0628	CbGbCtD
Raloxifene—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0449	0.0628	CbGbCtD
Raloxifene—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0449	0.0628	CbGbCtD
Raloxifene—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.034	0.0476	CbGbCtD
Raloxifene—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.034	0.0476	CbGbCtD
Raloxifene—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0326	0.0456	CbGbCtD
Raloxifene—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0214	0.0299	CbGbCtD
Raloxifene—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0201	0.0282	CbGbCtD
Raloxifene—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0201	0.0282	CbGbCtD
Raloxifene—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0182	0.0255	CbGbCtD
Raloxifene—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0182	0.0255	CbGbCtD
Raloxifene—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0157	0.022	CbGbCtD
Raloxifene—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0153	0.0213	CbGbCtD
Raloxifene—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0138	0.0193	CbGbCtD
Raloxifene—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0138	0.0193	CbGbCtD
Raloxifene—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0132	0.0185	CbGbCtD
Raloxifene—CYP19A1—semen—acquired immunodeficiency syndrome	0.00614	0.116	CbGeAlD
Raloxifene—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.0016	0.0303	CbGeAlD
Raloxifene—CYP2B6—blood plasma—acquired immunodeficiency syndrome	0.00144	0.0272	CbGeAlD
Raloxifene—HTR6—nervous system—acquired immunodeficiency syndrome	0.0012	0.0227	CbGeAlD
Raloxifene—HTR6—central nervous system—acquired immunodeficiency syndrome	0.00116	0.0219	CbGeAlD
Raloxifene—ESR2—lymphoid tissue—acquired immunodeficiency syndrome	0.0011	0.0209	CbGeAlD
Raloxifene—ESR2—digestive system—acquired immunodeficiency syndrome	0.00109	0.0206	CbGeAlD
Raloxifene—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00108	0.0205	CbGeAlD
Raloxifene—HTR2B—skin of body—acquired immunodeficiency syndrome	0.00105	0.0199	CbGeAlD
Raloxifene—AOX1—digestive system—acquired immunodeficiency syndrome	0.00105	0.0199	CbGeAlD
Raloxifene—ESR2—blood—acquired immunodeficiency syndrome	0.00104	0.0197	CbGeAlD
Raloxifene—ESR2—vagina—acquired immunodeficiency syndrome	0.000964	0.0182	CbGeAlD
Raloxifene—AOX1—vagina—acquired immunodeficiency syndrome	0.000927	0.0175	CbGeAlD
Raloxifene—HTR6—brain—acquired immunodeficiency syndrome	0.000919	0.0174	CbGeAlD
Raloxifene—ESR2—lung—acquired immunodeficiency syndrome	0.000911	0.0172	CbGeAlD
Raloxifene—AOX1—lung—acquired immunodeficiency syndrome	0.000877	0.0166	CbGeAlD
Raloxifene—ESR2—nervous system—acquired immunodeficiency syndrome	0.000844	0.016	CbGeAlD
Raloxifene—HTR2B—digestive system—acquired immunodeficiency syndrome	0.000843	0.016	CbGeAlD
Raloxifene—CYP19A1—blood—acquired immunodeficiency syndrome	0.000819	0.0155	CbGeAlD
Raloxifene—ESR2—central nervous system—acquired immunodeficiency syndrome	0.000812	0.0154	CbGeAlD
Raloxifene—SIGMAR1—blood—acquired immunodeficiency syndrome	0.000805	0.0152	CbGeAlD
Raloxifene—HTR2B—blood—acquired immunodeficiency syndrome	0.000804	0.0152	CbGeAlD
Raloxifene—SIGMAR1—bone marrow—acquired immunodeficiency syndrome	0.000779	0.0147	CbGeAlD
Raloxifene—SIGMAR1—spinal cord—acquired immunodeficiency syndrome	0.000776	0.0147	CbGeAlD
Raloxifene—ESR1—lymphoid tissue—acquired immunodeficiency syndrome	0.000757	0.0143	CbGeAlD
Raloxifene—ESR1—digestive system—acquired immunodeficiency syndrome	0.000747	0.0141	CbGeAlD
Raloxifene—SIGMAR1—vagina—acquired immunodeficiency syndrome	0.000747	0.0141	CbGeAlD
Raloxifene—HTR2B—vagina—acquired immunodeficiency syndrome	0.000745	0.0141	CbGeAlD
Raloxifene—ESR1—blood—acquired immunodeficiency syndrome	0.000712	0.0135	CbGeAlD
Raloxifene—SIGMAR1—lung—acquired immunodeficiency syndrome	0.000706	0.0134	CbGeAlD
Raloxifene—HTR2B—lung—acquired immunodeficiency syndrome	0.000704	0.0133	CbGeAlD
Raloxifene—CYP2B6—skin of body—acquired immunodeficiency syndrome	0.00069	0.0131	CbGeAlD
Raloxifene—CYP19A1—nervous system—acquired immunodeficiency syndrome	0.000665	0.0126	CbGeAlD
Raloxifene—ESR1—vagina—acquired immunodeficiency syndrome	0.00066	0.0125	CbGeAlD
Raloxifene—HTR2B—nervous system—acquired immunodeficiency syndrome	0.000652	0.0123	CbGeAlD
Raloxifene—ESR2—brain—acquired immunodeficiency syndrome	0.000645	0.0122	CbGeAlD
Raloxifene—CYP19A1—central nervous system—acquired immunodeficiency syndrome	0.00064	0.0121	CbGeAlD
Raloxifene—HTR2B—central nervous system—acquired immunodeficiency syndrome	0.000628	0.0119	CbGeAlD
Raloxifene—ESR1—lung—acquired immunodeficiency syndrome	0.000624	0.0118	CbGeAlD
Raloxifene—ESR2—lymph node—acquired immunodeficiency syndrome	0.000623	0.0118	CbGeAlD
Raloxifene—AOX1—brain—acquired immunodeficiency syndrome	0.000621	0.0117	CbGeAlD
Raloxifene—AOX1—lymph node—acquired immunodeficiency syndrome	0.0006	0.0113	CbGeAlD
Raloxifene—CYP2C8—blood—acquired immunodeficiency syndrome	0.000586	0.0111	CbGeAlD
Raloxifene—ESR1—nervous system—acquired immunodeficiency syndrome	0.000578	0.0109	CbGeAlD
Raloxifene—CYP2B6—lymphoid tissue—acquired immunodeficiency syndrome	0.000559	0.0106	CbGeAlD
Raloxifene—ESR1—central nervous system—acquired immunodeficiency syndrome	0.000556	0.0105	CbGeAlD
Raloxifene—CYP2B6—digestive system—acquired immunodeficiency syndrome	0.000552	0.0104	CbGeAlD
Raloxifene—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000544	0.0103	CbGeAlD
Raloxifene—CYP2B6—blood—acquired immunodeficiency syndrome	0.000526	0.00995	CbGeAlD
Raloxifene—CYP19A1—brain—acquired immunodeficiency syndrome	0.000508	0.00962	CbGeAlD
Raloxifene—SIGMAR1—brain—acquired immunodeficiency syndrome	0.0005	0.00945	CbGeAlD
Raloxifene—HTR2B—brain—acquired immunodeficiency syndrome	0.000499	0.00943	CbGeAlD
Raloxifene—CYP19A1—lymph node—acquired immunodeficiency syndrome	0.000491	0.00929	CbGeAlD
Raloxifene—CYP2B6—vagina—acquired immunodeficiency syndrome	0.000488	0.00923	CbGeAlD
Raloxifene—SIGMAR1—lymph node—acquired immunodeficiency syndrome	0.000483	0.00913	CbGeAlD
Raloxifene—HTR2B—lymph node—acquired immunodeficiency syndrome	0.000482	0.00911	CbGeAlD
Raloxifene—CYP2B6—lung—acquired immunodeficiency syndrome	0.000461	0.00872	CbGeAlD
Raloxifene—ESR1—brain—acquired immunodeficiency syndrome	0.000442	0.00836	CbGeAlD
Raloxifene—CYP2B6—nervous system—acquired immunodeficiency syndrome	0.000427	0.00808	CbGeAlD
Raloxifene—ESR1—lymph node—acquired immunodeficiency syndrome	0.000427	0.00808	CbGeAlD
Raloxifene—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000417	0.00789	CbGeAlD
Raloxifene—CYP2B6—central nervous system—acquired immunodeficiency syndrome	0.000411	0.00778	CbGeAlD
Raloxifene—CYP3A4—blood—acquired immunodeficiency syndrome	0.000397	0.00752	CbGeAlD
Raloxifene—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000366	0.00158	CcSEcCtD
Raloxifene—Muscle spasms—Delavirdine—acquired immunodeficiency syndrome	0.000365	0.00158	CcSEcCtD
Raloxifene—CYP2C8—brain—acquired immunodeficiency syndrome	0.000364	0.00688	CbGeAlD
Raloxifene—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000364	0.00157	CcSEcCtD
Raloxifene—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000364	0.00157	CcSEcCtD
Raloxifene—Pain—Stavudine—acquired immunodeficiency syndrome	0.000363	0.00156	CcSEcCtD
Raloxifene—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00156	CcSEcCtD
Raloxifene—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.00156	CcSEcCtD
Raloxifene—Thrombocytopenia—Zidovudine—acquired immunodeficiency syndrome	0.000361	0.00156	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00156	CcSEcCtD
Raloxifene—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.00036	0.00155	CcSEcCtD
Raloxifene—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.000359	0.00155	CcSEcCtD
Raloxifene—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000358	0.00154	CcSEcCtD
Raloxifene—Myalgia—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00154	CcSEcCtD
Raloxifene—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00154	CcSEcCtD
Raloxifene—Arthralgia—Indinavir—acquired immunodeficiency syndrome	0.000357	0.00154	CcSEcCtD
Raloxifene—Pain—Abacavir—acquired immunodeficiency syndrome	0.000357	0.00154	CcSEcCtD
Raloxifene—Vertigo—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00154	CcSEcCtD
Raloxifene—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000356	0.00154	CcSEcCtD
Raloxifene—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000356	0.00154	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000355	0.00153	CcSEcCtD
Raloxifene—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000352	0.00152	CcSEcCtD
Raloxifene—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000349	0.0015	CcSEcCtD
Raloxifene—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000348	0.0015	CcSEcCtD
Raloxifene—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.000347	0.0015	CcSEcCtD
Raloxifene—Body temperature increased—Nevirapine—acquired immunodeficiency syndrome	0.000347	0.0015	CcSEcCtD
Raloxifene—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.000347	0.0015	CcSEcCtD
Raloxifene—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000346	0.00149	CcSEcCtD
Raloxifene—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.000346	0.00149	CcSEcCtD
Raloxifene—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.000341	0.00147	CcSEcCtD
Raloxifene—Vertigo—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.00147	CcSEcCtD
Raloxifene—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000341	0.00147	CcSEcCtD
Raloxifene—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00147	CcSEcCtD
Raloxifene—Arthralgia—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00146	CcSEcCtD
Raloxifene—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00146	CcSEcCtD
Raloxifene—Myalgia—Efavirenz—acquired immunodeficiency syndrome	0.000338	0.00146	CcSEcCtD
Raloxifene—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000338	0.00146	CcSEcCtD
Raloxifene—Muscle spasms—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.00146	CcSEcCtD
Raloxifene—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000337	0.00146	CcSEcCtD
Raloxifene—Shock—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00146	CcSEcCtD
Raloxifene—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.000336	0.00145	CcSEcCtD
Raloxifene—Body temperature increased—Nelfinavir—acquired immunodeficiency syndrome	0.000336	0.00145	CcSEcCtD
Raloxifene—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00145	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000336	0.00145	CcSEcCtD
Raloxifene—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000336	0.00145	CcSEcCtD
Raloxifene—Thrombocytopenia—Indinavir—acquired immunodeficiency syndrome	0.000335	0.00145	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.00145	CcSEcCtD
Raloxifene—Body temperature increased—Stavudine—acquired immunodeficiency syndrome	0.000335	0.00145	CcSEcCtD
Raloxifene—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.000335	0.00145	CcSEcCtD
Raloxifene—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000334	0.00144	CcSEcCtD
Raloxifene—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.000334	0.00144	CcSEcCtD
Raloxifene—Insomnia—Zidovudine—acquired immunodeficiency syndrome	0.000333	0.00144	CcSEcCtD
Raloxifene—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.000333	0.00144	CcSEcCtD
Raloxifene—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000333	0.00144	CcSEcCtD
Raloxifene—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000331	0.00143	CcSEcCtD
Raloxifene—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000331	0.00143	CcSEcCtD
Raloxifene—Body temperature increased—Abacavir—acquired immunodeficiency syndrome	0.00033	0.00142	CcSEcCtD
Raloxifene—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00033	0.00142	CcSEcCtD
Raloxifene—CYP2B6—brain—acquired immunodeficiency syndrome	0.000326	0.00618	CbGeAlD
Raloxifene—Muscle spasms—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.0014	CcSEcCtD
Raloxifene—Dyspepsia—Zidovudine—acquired immunodeficiency syndrome	0.000324	0.0014	CcSEcCtD
Raloxifene—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00139	CcSEcCtD
Raloxifene—Myalgia—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00139	CcSEcCtD
Raloxifene—Arthralgia—Delavirdine—acquired immunodeficiency syndrome	0.000323	0.00139	CcSEcCtD
Raloxifene—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000322	0.0061	CbGeAlD
Raloxifene—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.00137	CcSEcCtD
Raloxifene—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000318	0.00137	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000318	0.00137	CcSEcCtD
Raloxifene—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.000318	0.00137	CcSEcCtD
Raloxifene—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.00137	CcSEcCtD
Raloxifene—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.00137	CcSEcCtD
Raloxifene—Vertigo—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00136	CcSEcCtD
Raloxifene—Pain—Zidovudine—acquired immunodeficiency syndrome	0.000315	0.00136	CcSEcCtD
Raloxifene—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00136	CcSEcCtD
Raloxifene—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.00136	CcSEcCtD
Raloxifene—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000313	0.00135	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000312	0.00135	CcSEcCtD
Raloxifene—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00031	0.00587	CbGeAlD
Raloxifene—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.00031	0.00134	CcSEcCtD
Raloxifene—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.00031	0.00134	CcSEcCtD
Raloxifene—Muscle spasms—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.00134	CcSEcCtD
Raloxifene—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000308	0.00133	CcSEcCtD
Raloxifene—Rash—Didanosine—acquired immunodeficiency syndrome	0.000308	0.00133	CcSEcCtD
Raloxifene—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00133	CcSEcCtD
Raloxifene—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000308	0.00133	CcSEcCtD
Raloxifene—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000306	0.00132	CcSEcCtD
Raloxifene—Headache—Didanosine—acquired immunodeficiency syndrome	0.000306	0.00132	CcSEcCtD
Raloxifene—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000305	0.00132	CcSEcCtD
Raloxifene—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.00131	CcSEcCtD
Raloxifene—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.00131	CcSEcCtD
Raloxifene—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00131	CcSEcCtD
Raloxifene—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000302	0.0013	CcSEcCtD
Raloxifene—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000301	0.0013	CcSEcCtD
Raloxifene—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.0013	CcSEcCtD
Raloxifene—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.0003	0.0013	CcSEcCtD
Raloxifene—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000299	0.00129	CcSEcCtD
Raloxifene—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00129	CcSEcCtD
Raloxifene—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00129	CcSEcCtD
Raloxifene—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000299	0.00129	CcSEcCtD
Raloxifene—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000297	0.00128	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00128	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00128	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000295	0.00127	CcSEcCtD
Raloxifene—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00127	CcSEcCtD
Raloxifene—Pain—Indinavir—acquired immunodeficiency syndrome	0.000293	0.00126	CcSEcCtD
Raloxifene—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000293	0.00126	CcSEcCtD
Raloxifene—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00126	CcSEcCtD
Raloxifene—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000291	0.00126	CcSEcCtD
Raloxifene—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000291	0.00126	CcSEcCtD
Raloxifene—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00029	0.00125	CcSEcCtD
Raloxifene—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00029	0.00125	CcSEcCtD
Raloxifene—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.00125	CcSEcCtD
Raloxifene—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00125	CcSEcCtD
Raloxifene—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00124	CcSEcCtD
Raloxifene—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00124	CcSEcCtD
Raloxifene—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000288	0.00124	CcSEcCtD
Raloxifene—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000286	0.00123	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.00123	CcSEcCtD
Raloxifene—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000285	0.00123	CcSEcCtD
Raloxifene—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000283	0.00122	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000282	0.00122	CcSEcCtD
Raloxifene—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000282	0.00122	CcSEcCtD
Raloxifene—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000281	0.00121	CcSEcCtD
Raloxifene—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000281	0.00121	CcSEcCtD
Raloxifene—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00121	CcSEcCtD
Raloxifene—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.00121	CcSEcCtD
Raloxifene—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.00028	0.00121	CcSEcCtD
Raloxifene—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00028	0.00121	CcSEcCtD
Raloxifene—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.00028	0.00121	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00121	CcSEcCtD
Raloxifene—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000279	0.0012	CcSEcCtD
Raloxifene—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.0012	CcSEcCtD
Raloxifene—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000277	0.0012	CcSEcCtD
Raloxifene—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000277	0.0012	CcSEcCtD
Raloxifene—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00119	CcSEcCtD
Raloxifene—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000277	0.00119	CcSEcCtD
Raloxifene—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000276	0.00119	CcSEcCtD
Raloxifene—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000275	0.00119	CcSEcCtD
Raloxifene—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00118	CcSEcCtD
Raloxifene—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00118	CcSEcCtD
Raloxifene—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000274	0.00118	CcSEcCtD
Raloxifene—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00118	CcSEcCtD
Raloxifene—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000273	0.00118	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.00118	CcSEcCtD
Raloxifene—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00117	CcSEcCtD
Raloxifene—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00117	CcSEcCtD
Raloxifene—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000271	0.00117	CcSEcCtD
Raloxifene—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00117	CcSEcCtD
Raloxifene—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00027	0.00117	CcSEcCtD
Raloxifene—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.00117	CcSEcCtD
Raloxifene—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00027	0.00116	CcSEcCtD
Raloxifene—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00116	CcSEcCtD
Raloxifene—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000268	0.00116	CcSEcCtD
Raloxifene—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00116	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000267	0.00115	CcSEcCtD
Raloxifene—Rash—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00115	CcSEcCtD
Raloxifene—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000267	0.00115	CcSEcCtD
Raloxifene—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000267	0.00115	CcSEcCtD
Raloxifene—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000266	0.00115	CcSEcCtD
Raloxifene—Headache—Stavudine—acquired immunodeficiency syndrome	0.000266	0.00115	CcSEcCtD
Raloxifene—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000266	0.00115	CcSEcCtD
Raloxifene—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000265	0.00114	CcSEcCtD
Raloxifene—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000265	0.00114	CcSEcCtD
Raloxifene—Rash—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00114	CcSEcCtD
Raloxifene—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000263	0.00114	CcSEcCtD
Raloxifene—Headache—Abacavir—acquired immunodeficiency syndrome	0.000262	0.00113	CcSEcCtD
Raloxifene—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000261	0.00113	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000261	0.00113	CcSEcCtD
Raloxifene—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000261	0.00113	CcSEcCtD
Raloxifene—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000259	0.00112	CcSEcCtD
Raloxifene—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.00112	CcSEcCtD
Raloxifene—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00111	CcSEcCtD
Raloxifene—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00111	CcSEcCtD
Raloxifene—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.0011	CcSEcCtD
Raloxifene—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000256	0.0011	CcSEcCtD
Raloxifene—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.0011	CcSEcCtD
Raloxifene—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000254	0.0011	CcSEcCtD
Raloxifene—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000253	0.00109	CcSEcCtD
Raloxifene—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000253	0.00109	CcSEcCtD
Raloxifene—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000252	0.00109	CcSEcCtD
Raloxifene—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000252	0.00109	CcSEcCtD
Raloxifene—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000252	0.00109	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000251	0.00108	CcSEcCtD
Raloxifene—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.00108	CcSEcCtD
Raloxifene—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000248	0.00107	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00107	CcSEcCtD
Raloxifene—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000245	0.00106	CcSEcCtD
Raloxifene—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00106	CcSEcCtD
Raloxifene—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000245	0.00106	CcSEcCtD
Raloxifene—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00105	CcSEcCtD
Raloxifene—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000243	0.00105	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00024	0.00103	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00103	CcSEcCtD
Raloxifene—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000238	0.00103	CcSEcCtD
Raloxifene—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000236	0.00102	CcSEcCtD
Raloxifene—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000234	0.00101	CcSEcCtD
Raloxifene—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000234	0.00101	CcSEcCtD
Raloxifene—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000234	0.00101	CcSEcCtD
Raloxifene—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.001	CcSEcCtD
Raloxifene—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000232	0.001	CcSEcCtD
Raloxifene—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000232	0.000999	CcSEcCtD
Raloxifene—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000231	0.000996	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00098	CcSEcCtD
Raloxifene—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000227	0.000978	CcSEcCtD
Raloxifene—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000977	CcSEcCtD
Raloxifene—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000226	0.000977	CcSEcCtD
Raloxifene—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000225	0.000973	CcSEcCtD
Raloxifene—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000225	0.000971	CcSEcCtD
Raloxifene—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.000956	CcSEcCtD
Raloxifene—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000219	0.000945	CcSEcCtD
Raloxifene—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000941	CcSEcCtD
Raloxifene—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000218	0.000941	CcSEcCtD
Raloxifene—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000218	0.00094	CcSEcCtD
Raloxifene—Rash—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000933	CcSEcCtD
Raloxifene—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000216	0.000932	CcSEcCtD
Raloxifene—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000215	0.000928	CcSEcCtD
Raloxifene—Headache—Indinavir—acquired immunodeficiency syndrome	0.000215	0.000927	CcSEcCtD
Raloxifene—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000214	0.000924	CcSEcCtD
Raloxifene—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000915	CcSEcCtD
Raloxifene—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000898	CcSEcCtD
Raloxifene—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000898	CcSEcCtD
Raloxifene—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000889	CcSEcCtD
Raloxifene—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000884	CcSEcCtD
Raloxifene—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.000881	CcSEcCtD
Raloxifene—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000204	0.00088	CcSEcCtD
Raloxifene—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000879	CcSEcCtD
Raloxifene—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.000875	CcSEcCtD
Raloxifene—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.00085	CcSEcCtD
Raloxifene—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000846	CcSEcCtD
Raloxifene—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000843	CcSEcCtD
Raloxifene—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000195	0.000842	CcSEcCtD
Raloxifene—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000838	CcSEcCtD
Raloxifene—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.00083	CcSEcCtD
Raloxifene—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000818	CcSEcCtD
Raloxifene—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000814	CcSEcCtD
Raloxifene—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000794	CcSEcCtD
Raloxifene—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000182	0.000787	CcSEcCtD
Raloxifene—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000786	CcSEcCtD
Raloxifene—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.00078	CcSEcCtD
Raloxifene—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000779	CcSEcCtD
Raloxifene—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000777	CcSEcCtD
Raloxifene—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000179	0.000775	CcSEcCtD
Raloxifene—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000757	CcSEcCtD
Raloxifene—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000751	CcSEcCtD
Raloxifene—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00075	CcSEcCtD
Raloxifene—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.00075	CcSEcCtD
Raloxifene—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000746	CcSEcCtD
Raloxifene—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000734	CcSEcCtD
Raloxifene—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000722	CcSEcCtD
Raloxifene—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000716	CcSEcCtD
Raloxifene—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000715	CcSEcCtD
Raloxifene—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000711	CcSEcCtD
Raloxifene—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000707	CcSEcCtD
Raloxifene—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000674	CcSEcCtD
